-
公开(公告)号:US20230121700A1
公开(公告)日:2023-04-20
申请号:US17816855
申请日:2022-08-02
Applicant: Genentech, Inc.
Inventor: Jack Alexander TERRETT , Huifen CHEN , Lea CONSTANTINEAU-FORGET , Robin Larouche-Gauthier , Luce LÉPISSIER , Francis BEAUMIER , Martin DÉRY , Chantal GRAND-MAÎTRE , Claudio STURINO , Matthew VOLGRAF , Elisia VILLEMURE
IPC: C07D413/14 , C07D473/30 , C07D471/04 , A61P29/00 , C07D513/04 , C07D487/04 , A61P25/00 , C07D498/04 , A61K31/427 , A61P23/00 , A61P11/00
Abstract: The invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof wherein A, X, R1, R4 and n are as defined herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.
-
公开(公告)号:US20200002340A1
公开(公告)日:2020-01-02
申请号:US16558718
申请日:2019-09-03
Applicant: Genentech, Inc.
Inventor: Huifen CHEN , Brian SAFINA , Daniel SHORE , Jack TERRETT , Elisia VILLEMURE , Matthew VOLGRAF , Stuart WARD , Aijun LU , Robin LAROUCHE-GAUTHIER , Francis BEAUMIER , Martin DERY , Lea CONSTANTINEAU-FORGET , Chantal GRAND-MAITRE , Luce LEPISSIER
IPC: C07D473/30 , C07D471/04 , C07D487/04 , C07D473/08
Abstract: The invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.
-
公开(公告)号:US20250122184A1
公开(公告)日:2025-04-17
申请号:US18985661
申请日:2024-12-18
Applicant: Genentech, Inc.
Inventor: Jack Alexander TERRETT , Huifen CHEN , Lea CONSTANTINEAU-FORGET , Robin Larouche-Gauthier , Luce LÉPISSIER , Francis BEAUMIER , Martin DÉRY , Chantal GRAND-MAÎTRE , Claudio STURINO , Matthew VOLGRAF , Elisia VILLEMURE
IPC: C07D413/14 , A61K31/427 , A61P11/00 , A61P23/00 , A61P25/00 , A61P29/00 , C07D471/04 , C07D473/30 , C07D487/04 , C07D498/04 , C07D513/04
Abstract: The invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof wherein A, X, R1, R4 and n are as defined herein. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula I as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as pain.
-
公开(公告)号:US20190284189A1
公开(公告)日:2019-09-19
申请号:US16421114
申请日:2019-05-23
Applicant: Genentech, Inc.
Inventor: Huifen CHEN , Daniel SHORE , Elisia VILLEMURE , Matthew VOLGRAF , Baihua HU , Aijun LU , Andrew CRIDLAND , Stuart WARD , Francis BEAUMIER , Martin DERY , Robin LAROUCHE-GAUTHIER
IPC: C07D473/30 , C07D471/04 , C07D513/04 , C07D487/04
Abstract: The invention relates to compounds of formula (I): and pharmaceutically acceptable salts thereof. In addition, the present invention relates to methods of manufacturing and methods of using the compounds of formula (I) as well as pharmaceutical compositions containing such compounds. The compounds may be useful in treating diseases and conditions mediated by TRPA1, such as respiratory disorders or pain.
-
-
-